This project has been flagged by a community member as inappropriate due to reason below.*
Slingshot & STAT have partnered to provide you with interviews with experts led by STAT's reporters. This call is on:

Making sense of the NASH market and where the leading development compounds stand after data presented at EASL 2019

Ticker(s): ICPT, AGN

Who's the expert?

A thought leader in the NASH space who is familiar with the OCA data.

Interview Goal
This conversation will discuss the current compounds in development and competitive landscape for NASH and PBC patients. This call will also dig into Intercept's REGENERATE results for OCA which will be presented at the European Association for the Study of the Liver (EASL): The International Liver Congress 2019.

Are You Interested In These Questions?



22Days Left to Join Project

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.